Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer - Drug Trials For Money - Paid Clinical Trials

SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer

SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer
Conditions:   COVID-19-Associated Acute Respiratory Distress Syndrome;   COVID-19-Associated Pneumonia;   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm;   Symptomatic COVID-19 Infection Laboratory-Confirmed
Intervention:   Biological: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
Sponsor:   M.D. Anderson Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 9, 2021 / by / in
Comments